Genomic Analysis and Prediction Models for Metastasis in Lung Cancer
Author Information
Author(s): Wang Kangwei, Ye Meifeng, Mo Zexun, Huang Xiaomei, Li Yujun, Wei Shuquan
Primary Institution: Guangzhou First People's Hospital, South China University of Technology
Hypothesis
What are the genomic alterations and prognostic biomarkers associated with metastasis in non-small cell lung cancer?
Conclusion
The study identified genomic alterations in metastatic non-small cell lung cancer and developed predictive models for metastasis.
Supporting Evidence
- TP53 was the most frequent mutation in both metastatic and non-metastatic groups.
- Predictive models for metastasis showed an AUC of 0.828.
- Patients aged ≥ 70 years had a higher proportion in the metastatic group.
Takeaway
Researchers studied lung cancer patients to find out how their genes affect the spread of cancer and created models to predict who might have metastasis.
Methodology
Tumor sequencing of 556 cancer-related genes was performed on 114 NSCLC patients, and various statistical analyses were conducted to identify factors related to metastasis.
Potential Biases
Potential confounding factors and selective bias due to the single-institution study design.
Limitations
The study was conducted at a single institution with a relatively small sample size, which may limit the applicability of the results.
Participant Demographics
The median age of participants was 67 years, with 66.7% male and 54.4% having a smoking history.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website